Latest Articles
Zearalenone promotes endometrial cancer cell migration and invasion via activation of estrogen receptor-mediated Rho/ROCK/PMLC signaling pathway.
Zearalenone (ZEA), has emerged as a potential endocrine-disrupting chemical (EDC). Previous results show ZEA effects on endometrial stromal cell apoptosis, migration, and growth of endometriosis. Despite the reported presence of …
Published: Sept. 19, 2024, midnight
MSK Endometrial Cancer e-Tumor Board - Medscape
MSK Endometrial Cancer e-Tumor Board Medscape
Published: July 12, 2024, 7 a.m.
Ultrasound Screening Often Misses Endometrial Cancer in Black Females - Healthline
Ultrasound Screening Often Misses Endometrial Cancer in Black Females Healthline
Published: July 9, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today
Published: July 5, 2024, 7 a.m.
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer OncLive
Published: July 3, 2024, 7 a.m.
Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women - Healio
Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women Healio
Published: July 3, 2024, 7 a.m.
Durvalumab-Based Regimen Improves Overall Response Rate in Endometrial Cancer - www.oncnursingnews.com/
Durvalumab-Based Regimen Improves Overall Response Rate in Endometrial Cancer www.oncnursingnews.com/
Published: July 2, 2024, 7 a.m.
Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women - HealthDay
Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women HealthDay
Published: July 2, 2024, 7 a.m.
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer OncLive
Published: July 1, 2024, 7 a.m.
AI identifies new high-risk subtype in endometrial cancer - News-Medical.Net
AI identifies new high-risk subtype in endometrial cancer News-Medical.Net
Published: June 28, 2024, 7 a.m.
Link copied to clipboard!